OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · IEX Real-Time Price · USD
10.70
0.00 (0.00%)
Jul 26, 2024, 4:00 PM EDT - Market closed
OptimizeRx Revenue
OptimizeRx had revenue of $19.69M in the quarter ending March 31, 2024, with 51.43% growth. This brings the company's revenue in the last twelve months to $78.21M, up 26.71% year-over-year. In the year 2023, OptimizeRx had annual revenue of $71.52M with 14.53% growth.
Revenue (ttm)
$78.21M
Revenue Growth
+26.71%
P/S Ratio
2.50
Revenue / Employee
$575,063
Employees
136
Market Cap
195.49M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 71.52M | 9.07M | 14.53% |
Dec 31, 2022 | 62.45M | 1.16M | 1.89% |
Dec 31, 2021 | 61.29M | 17.98M | 41.51% |
Dec 31, 2020 | 43.31M | 18.72M | 76.08% |
Dec 31, 2019 | 24.60M | 3.39M | 15.99% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Coherus BioSciences | 301.87M |
Rigel Pharmaceuticals | 120.35M |
Biodesix | 54.85M |
908 Devices | 50.73M |
Fennec Pharmaceuticals | 44.95M |
MediWound | 19.85M |
Fractyl Health | 148.00K |
OPRX News
- 1 day ago - OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET - GlobeNewsWire
- 3 days ago - OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation - GlobeNewsWire
- 11 days ago - OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients - GlobeNewsWire
- 5 weeks ago - New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations - GlobeNewsWire
- 2 months ago - OptimizeRx Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - OptimizeRx to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET - GlobeNewsWire
- 3 months ago - OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report - GlobeNewsWire